School of Mathematical Sciences and SJTU-Yale Joint Center for Biostatistics and Data Science, Shanghai Jiao Tong University, Shanghai 200240, China.
Peng Cheng Laboratory, Shenzhen, Guangdong 518055, China.
Brief Bioinform. 2024 Jan 22;25(2). doi: 10.1093/bib/bbae103.
Numerous investigations increasingly indicate the significance of microRNA (miRNA) in human diseases. Hence, unearthing associations between miRNA and diseases can contribute to precise diagnosis and efficacious remediation of medical conditions. The detection of miRNA-disease linkages via computational techniques utilizing biological information has emerged as a cost-effective and highly efficient approach. Here, we introduced a computational framework named ReHoGCNES, designed for prospective miRNA-disease association prediction (ReHoGCNES-MDA). This method constructs homogenous graph convolutional network with regular graph structure (ReHoGCN) encompassing disease similarity network, miRNA similarity network and known MDA network and then was tested on four experimental tasks. A random edge sampler strategy was utilized to expedite processes and diminish training complexity. Experimental results demonstrate that the proposed ReHoGCNES-MDA method outperforms both homogenous graph convolutional network and heterogeneous graph convolutional network with non-regular graph structure in all four tasks, which implicitly reveals steadily degree distribution of a graph does play an important role in enhancement of model performance. Besides, ReHoGCNES-MDA is superior to several machine learning algorithms and state-of-the-art methods on the MDA prediction. Furthermore, three case studies were conducted to further demonstrate the predictive ability of ReHoGCNES. Consequently, 93.3% (breast neoplasms), 90% (prostate neoplasms) and 93.3% (prostate neoplasms) of the top 30 forecasted miRNAs were validated by public databases. Hence, ReHoGCNES-MDA might serve as a dependable and beneficial model for predicting possible MDAs.
大量研究越来越表明 microRNA(miRNA)在人类疾病中的重要性。因此,挖掘 miRNA 与疾病之间的关联可以有助于对疾病进行精确诊断和有效治疗。利用生物信息学通过计算技术检测 miRNA-疾病关联已成为一种具有成本效益且高效的方法。在这里,我们引入了一种名为 ReHoGCNES 的计算框架,用于前瞻性 miRNA-疾病关联预测(ReHoGCNES-MDA)。该方法构建了具有正则图结构的同质图卷积网络(ReHoGCN),包含疾病相似性网络、miRNA 相似性网络和已知的 MDA 网络,然后在四个实验任务中进行了测试。采用随机边采样策略来加速过程并降低训练复杂度。实验结果表明,在所提出的 ReHoGCNES-MDA 方法在所有四个任务中均优于同质图卷积网络和具有非正则图结构的异质图卷积网络,这表明图的稳定度分布在增强模型性能方面起着重要作用。此外,ReHoGCNES-MDA 在 MDA 预测方面优于几种机器学习算法和最新方法。此外,还进行了三个案例研究以进一步证明 ReHoGCNES 的预测能力。结果,通过公共数据库验证了前 30 个预测 miRNA 中的 93.3%(乳腺肿瘤)、90%(前列腺肿瘤)和 93.3%(前列腺肿瘤)。因此,ReHoGCNES-MDA 可能成为预测可能的 MDA 的可靠和有益的模型。